arrow
Back
P

Philip J. Johnson

university of calgary

91H-index
431Paper Count
3.2WCitation Count
Published Papers 149
Publication Date
Chronic hepatitis in horses with persistent equine hepacivirus infection
err2025-12-01
err1
errOAAI
errJager, Mason C.; Luethy, Daniela; Shallop, Samantha; Cathcart, Jessica; Divers, Thomas J.; Tan, Jean-yin; Beasley, Erin Mcconachie; Johnson, Philip; Leduc, Laurence; Smith, Claire; Jamieson, Camilla Anne; Magdesian, K. Gary; Van De Walle, Gerlinde R.; Tomlinson, Joy E.
errShare
errSave
Repeated low-dose copper algaecide treatments promote beneficial phytoplankton and zooplankton communities
err2025-10-04
err0
errOAAI
errMichael B. McDonald; Ashley V. Hennessey; Peyton P. Johnson; Matthew F. Gladfelter; Kate L. Merrill; Suzanne E. Tenison; Sathya S. Ganegoda; Tham C. Hoang; H. Allen Torbert; Benjamin H. Beck; Alan E. Wilson
errShare
errSave
errShare
errSave
Estimating treatment effects using parametric models as counter-factual evidence
err2025-04-09
err0
errOAAI
errJackson, Richard; Johnson, Philip; Berhane, Sarah; Kolamunnage-Dona, Ruwanthi; Hughes, David; Dodd, Susanna; Neoptolemos, John; Palmer, Daniel; Cox, Trevor
errShare
errSave
Evaluating the tolerance of harmful algal bloom communities to copper
err2025-03-01
err0
errOAAI
errHennessey, Ashley V.; Mcdonald, Michael B.; Johnson, Peyton P.; Gladfelter, Matthew F.; Merrill, Kate L.; Tenison, Suzanne E.; Ganegoda, Sathya S.; Hoang, Tham C.; Torbert, H. Allen; Beck, Benjamin H.; Wilson, Alan E.
errShare
errSave
Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
err2024-08-27
err0
errOAAI
errHenry-Blake, Connor; Balachandrakumar, Vinay; Kassab, Mohamed; Devonport, Joshua; Matthews, Charmaine; Fox, James; Baggus, Elisabeth; Henney, Alexander; Stern, Nicholas; Cuthbertson, Daniel J.; Palmer, Daniel; Johnson, Philip J.; Hughes, David M.; Hydes, Theresa J.; Cross, Timothy J. S.
errShare
errSave
errShare
errSave
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma
err2024-01-01
err2
errOAAI
errToyoda, Hidenori; Kanneganti, Mounika; Melendez-Torres, Jonathan; Parikh, Neehar D.; Jalal, Prasun K.; Pinero, Federico; Mendizabal, Manuel; Ridruejo, Ezequiel; Cheinquer, Hugo; Casadei-Gardini, Andrea; Weinmann, Arndt; Peck-Radosavljevic, Markus; Dufour, Jean-Francois; Radu, Pompilia; Shiha, Gamal; Soliman, Riham; Sarin, Shiv K.; Kumar, Manoj; Wang, Jing-Houng; Tangkijvanich, Pisit; Sukeepaisarnjaroen, Wattana; Atsukawa, Masanori; Uojima, Haruki; Nozaki, Akito; Nakamuta, Makoto; Takaguchi, Koichi; Hiraoka, Atsushi; Abe, Hiroshi; Matsuur, Kentaro; Watanabe, Tsunamasa; Shimada, Noritomo; Tsuji, Kunihiko; Ishikawa, Toru; Mikami, Shigeru; Itobayashi, Ei; Singal, Amit G.; Johnson, Philip J.
errShare
errSave
Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
err2023-09-18
err2
errOAAI
errTruong, Thai Ngoc; Pham, Trang Ngoc Doan; Hoang, Long Bao; Nguyen, Van Thi; Dao, Hang Viet; Dao, Diem Vu Bich; Alessy, Saleh; Pham, Hien Ba; Pham, Thuy Thi Thu; Nguyen, Linh Duc Duy; Nguyen, Khue; Abaalkhail, Faisal; Manal, Mohammed; Mawardi, Mohammad; Alzahrani, May; Alswat, Khalid; Alghamdi, Hamdan; Sanai, Faisal M.; Siddiqui, Mohammed Amir; Nguyen, Nam Hai; Vaidya, Dhananjay; Phan, Hai Thanh; Johnson, Philip J.; Alqahtani, Saleh A.; Dao, Doan Y.
errShare
errSave
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study
err2023-08-02
err15
errOAAI
errHamill, Victoria; Wong, Stanley; Benselin, Jennifer; Krajden, Mel; Hayes, Peter C.; Mutimer, David; Yu, Amanda; Dillon, John F.; Gelson, William; Garcia, Hector A. Velasquez; Yeung, Alan; Johnson, Philip; Barclay, Stephen; Alvarez, Maria; Toyoda, Hidenori; Agarwal, Kosh; Fraser, Andrew; Bartlett, Sofia; Aldersley, Mark; Bathgate, Andy; Binka, Mawuena; Richardson, Paul; Morling, Joanne R.; Ryder, Stephen; MacDonald, Douglas; Hutchinson, Sharon; Barnes, Eleanor; Guha, Indra Neil; Irving, William L.; Janjua, Naveed Z.; Innes, Hamish
errShare
errSave
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?
err2023-02-17
err7
errOAAI
errCucchetti, Alessandro; Elshaarawy, Omar; Han, Guohong; Chong, Charing C. N.; Serra, Carla; O'Rourke, Joanne Marie; Crew, Richard; Felicani, Cristina; Ercolani, Giorgio; Shah, Tahir; Vogel, Arndt; Lai, Paul B. S.; Johnson, Philip J.
errShare
errSave
Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review
err2023-01-17
err4
errOAAI
errVogel, Arndt; Kelley, Robin Katie; Johnson, Philip; Merle, Philippe; Yau, Thomas; Kudo, Masatoshi; Meyer, Tim; Rimassa, Lorenza
errShare
errSave
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
err2022-07-07
err21
errOAAI
errJohnson, Philip J.; Innes, Hamish; Hughes, David M.; Kalyuzhnyy, Anton; Kumada, Takashi; Toyoda, Hidenori
errShare
errSave
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
err2022-06-24
err3
errOAAI
errInnes, Hamish; Hamill, Victoria; McDonald, Scott A.; Hayes, Peter C.; Johnson, Philip; Dillon, John F.; Bishop, Jen; Yeung, Alan; Went, April; Barclay, Stephen T.; Fraser, Andrew; Bathgate, Andrew; Goldberg, David J.; Hutchinson, Sharon J.
errShare
errSave
Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan
err2022-06-16
err12
PREAI
errToyoda, Hidenori; Kariyama, Kazuya; Hiraoka, Atsushi; Tsuji, Kunihiko; Ishikawa, Toru; Hatanaka, Takeshi; Naganuma, Atsushi; Yasuda, Satoshi; Nouso, Kazuhiro; Kakizaki, Satoru; Kumada, Takashi; Innes, Hamish; Johnson, Philip J.
errShare
errSave
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
err2022-02-10
err75
errOAAI
errKudo, Masatoshi; Ueshima, Kazuomi; Ikeda, Masafumi; Torimura, Takuji; Tanabe, Nobukazu; Aikata, Hiroshi; Izumi, Namiki; Yamasaki, Takahiro; Nojiri, Shunsuke; Hino, Keisuke; Tsumura, Hidetaka; Kuzuya, Teiji; Isoda, Norio; Moriguchi, Michihisa; Aino, Hajime; Ido, Akio; Kawabe, Naoto; Nakao, Kazuhiko; Wada, Yoshiyuki; Ogasawara, Sadahisa; Yoshimura, Kenichi; Okusaka, Takuji; Furuse, Junji; Kokudo, Norihiro; Okita, Kiwamu; Johnson, Philip James; Arai, Yasuaki
errShare
errSave
The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival
err2022-02-01
err8
errOAAI
errHydes, Theresa J.; Cuthbertson, Daniel J.; Graef, Suzanne; Berhane, Sarah; Teng, Mabel; Skowronska, Anna; Singh, Pushpa; Dhanaraj, Sofi; Abd Tahrani; Johnson, Philip J.
errShare
errSave
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
err2021-12-01
err19
errOAAI
errInnes, Hamish; Jepsen, Peter; McDonald, Scott; Dillon, John; Hamill, Victoria; Yeung, Alan; Benselin, Jennifer; Went, April; Fraser, Andrew; Bathgate, Andrew; Ansari, M. Azim; Barclay, Stephen T.; Goldberg, David; Hayes, Peter C.; Johnson, Philip; Barnes, Eleanor; Irving, William; Hutchinson, Sharon; Guha, Indra Neil
errShare
errSave